Evidence method
Level · gp.fundamentals.debt_to_revenue
164.93% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
LUNG · Jun 30, 2026
Pulmonx Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001127537-26-000039General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-22.91% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-4.62% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
72.02% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
77.97% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-39.80% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.12% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
16.25% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20250/9 normalizedLevel 3Sep 30, 20258/9 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/9 normalizedLevel 3Jun 30, 20268/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 181.25%
- Current
- 164.93%
- Delta
- -16.33%
- Previous
- 0.04%
- Current
- 0.00%
- Delta
- -0.04%
- Previous
- -49.05%
- Current
- -22.91%
- Delta
- 26.14%
- Previous
- -8.66%
- Current
- -4.62%
- Delta
- 4.04%
- Previous
- 79.23%
- Current
- 72.02%
- Delta
- -7.20%
- Previous
- 77.94%
- Current
- 77.97%
- Delta
- 0.03%
- Previous
- -62.94%
- Current
- -39.80%
- Delta
- 23.14%
- Previous
- 23.80%
- Current
- 22.12%
- Delta
- -1.68%
- Previous
- 20.09%
- Current
- 16.25%
- Delta
- -3.84%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Surgical & Medical Instruments & Apparatus peers →Transitioned To · LUNG Fundamental State →Transitioned To · LUNG BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · LUNG CAPEX_INTENSITY_DECREASED →Transitioned To · LUNG CASH_GENERATION_INCREASED →Transitioned To · LUNG GROWTH_INCREASED →Transitioned To · LUNG INVENTORY_PRESSURE_DECREASED →Transitioned To · LUNG MARGIN_INCREASED →Transitioned To · LUNG PROFITABILITY_INCREASED →Transitioned To · LUNG R_AND_D_INTENSITY_DECREASED →Transitioned To · LUNG SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.